LSE - Delayed Quote • GBp Genflow Biosciences plc (GENF.L) Follow Compare 1.9750 +0.0500 +(2.60%) At close: 3:00:15 PM GMT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Genflow Biosciences PLC Announces Holding(s) in Company - 2 1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Jonathan Mark Swann ... Genflow Biosciences PLC Announces Holding(s) in Company - 1 1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name Premier ... Genflow Biosciences PLC Announces 2024 Highlights 2024 has been an incredible year for Genflow as we advance our mission to develop novel therapeutics that promote a longer, healthier life. Our focus on the SIRT6 gene and its potential to slow aging and delay age-related diseases has seen significant ... Genflow Secures Non-Dilutive Financial Support THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ... OTC Markets Hosts Virtual Investor Presentation with Eric Leire, Founder & CEO of Genflow Biosciences, and Brad Sorensen, Senior Analyst at Zacks SCR OTCQB: GENFF | LSE: GENF OTC Markets: Hello and welcome to Virtual Investor Conferences. On behalf of OTC Markets and our co-host, Zacks Small-Cap Research, we're very pleased you have joined us for our next live presentation from Genflow Biosciences. Your session will be moderated by Brad Sorensen, Senior Equity Research Analyst with Zacks Small-Cap Research. Please note, you can submit Genflow Biosciences PLC Announces Half-year Report LONDON, UNITED KINGDOM / ACCESSWIRE / September 30, 2024 / Genflow (LSE:GENF) is pleased to announce its half year results for the six-month period ended 30 June 2024. Chairman's Statement It is with pleasure that I take this opportunity to update ... Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum held September 19th are now available for online viewing. This event was co-sponsored by Zacks Small-Cap Research. REGISTER NOW AT: https://bit.ly/3TuSFdy The company presentations will be available 24/ Life Sciences Virtual Investor Forum Agenda Announced for September 19th Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Virtual Investor Forum to be held September 19th. This event is co-sponsored by Zacks Small-Cap Research Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/3XnsBlt It Genflow Biosciences Plc to Present at the Life Sciences Investor Forum September 19th Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comLONDON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (LSE:GENF OTCQB:GENFF), based in the UK, focused on pioneering gene therapies to decelerate the aging process, today announced that Dr Eric Leire, Chief Executive Officer, will present live at the Life Sciences Investor Forum, hosted by VirtualInvestorConferences.com, on September 19th 2024. Genflow Biosciences Plc Announces Result of AGM LONDON, UNITED KINGDOM / ACCESSWIRE / June 27, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention ... Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ... Genflow Biosciences PLC Announces Receipt of Grant Funding Receipt of Grant Funding LONDON, UK / ACCESSWIRE / June 12, 2024 / THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT ... Genflow Biosciences PLC Announces Notice of AGM Genflow Biosciences Plc Notice of Annual General Meeting LONDON, UNITED KINGDOM / ACCESSWIRE / June 3, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused ... Genflow Biosciences PLC Announces Holding(s) in Company LONDON, UK / ACCESSWIRE / May 10, 2024 / TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of ... Genflow Biosciences PLC Announces Restoration of Listing THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ... Genflow Biosciences PLC Announces Final Results THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ... Genflow Biosciences PLC Announces Temporary Suspension THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ... Genflow Biosciences PLC Announces Total Voting Rights THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ... Genflow Biosciences PLC Announces Notification of Major Holdings LONDON, UK / ACCESSWIRE / April 10, 2024 / TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal ... Genflow Biosciences PLC Announces Notification of Major Holdings - 2 LONDON, UK / ACCESSWIRE / April 9, 2024 / Genflow Biosciences PLC Announces Notification of Major Holdings - 2: TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BP2C3V08 Issuer Name GENFLOW BIOSCIENCES PLC UK or Non-UK ... Performance Overview Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is FTSE 100 Return GENF.L FTSE 100 YTD +14.49% +0.99% 1-Year +19.70% +7.56% 3-Year -78.65% +8.43%